Marathon Trading Investment Management LLC acquired a new stake in shares of MetLife (NYSE:MET) during the fourth quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor acquired 10,300 shares of the financial services provider’s stock, valued at approximately $521,000.
A number of other institutional investors also recently modified their holdings of the stock. Avestar Capital LLC purchased a new stake in MetLife during the fourth quarter valued at approximately $135,000. Cramer Rosenthal Mcglynn LLC increased its holdings in MetLife by 1.0% during the fourth quarter. Cramer Rosenthal Mcglynn LLC now owns 317,427 shares of the financial services provider’s stock valued at $16,049,000 after buying an additional 3,297 shares during the last quarter. Premia Global Advisors LLC purchased a new stake in MetLife during the fourth quarter valued at approximately $170,000. Stone Ridge Asset Management LLC purchased a new stake in MetLife during the fourth quarter valued at approximately $1,225,000. Finally, Kendall Capital Management purchased a new stake in MetLife during the fourth quarter valued at approximately $366,000. Institutional investors own 77.64% of the company’s stock.
MetLife stock traded down $0.43 on Monday, reaching $46.89. 4,593,614 shares of the company traded hands, compared to its average volume of 7,404,156. The stock has a market capitalization of $49,053.95, a PE ratio of 13.79, a price-to-earnings-growth ratio of 0.96 and a beta of 1.28. MetLife has a 52 week low of $43.38 and a 52 week high of $55.91. The company has a quick ratio of 0.15, a current ratio of 0.15 and a debt-to-equity ratio of 0.29.
MetLife (NYSE:MET) last released its quarterly earnings data on Tuesday, February 13th. The financial services provider reported $0.64 EPS for the quarter, missing the Thomson Reuters’ consensus estimate of $1.05 by ($0.41). MetLife had a net margin of 5.69% and a return on equity of 8.59%. The business had revenue of $15.79 billion for the quarter, compared to the consensus estimate of $15.89 billion. During the same quarter last year, the business earned $1.28 EPS. analysts anticipate that MetLife will post 4.93 earnings per share for the current year.
The firm also recently disclosed a quarterly dividend, which was paid on Tuesday, March 13th. Shareholders of record on Monday, February 5th were given a dividend of $0.40 per share. The ex-dividend date was Friday, February 2nd. This represents a $1.60 annualized dividend and a yield of 3.41%. MetLife’s dividend payout ratio (DPR) is currently 46.92%.
A number of analysts have commented on the stock. UBS reaffirmed a “neutral” rating and set a $51.00 target price (down from $52.00) on shares of MetLife in a report on Friday, March 2nd. Morgan Stanley reduced their target price on shares of MetLife from $59.00 to $58.00 and set an “equal weight” rating for the company in a report on Wednesday, February 14th. Wells Fargo set a $60.00 target price on shares of MetLife and gave the company a “buy” rating in a report on Tuesday, February 13th. Goldman Sachs reaffirmed a “buy” rating on shares of MetLife in a report on Wednesday, January 31st. Finally, Keefe, Bruyette & Woods reaffirmed a “buy” rating and set a $56.00 target price on shares of MetLife in a report on Friday, February 23rd. One equities research analyst has rated the stock with a sell rating, ten have issued a hold rating, eight have issued a buy rating and one has issued a strong buy rating to the company’s stock. The company has an average rating of “Hold” and an average target price of $57.90.
MetLife, Inc, through its subsidiaries, engages in the insurance, annuities, employee benefits, and asset management businesses. It operates through five segments: U.S.; Asia; Latin America; Europe, the Middle East and Africa; and MetLife Holdings. The company offers life, dental, group short- and long-term disability, individual disability, accidental death and dismemberment, vision, and accident and health coverages, as well as prepaid legal plans; administrative services-only arrangements to employers; and stable value products, including general and separate account guaranteed interest contracts, and private floating rate funding agreements.
Receive News & Ratings for MetLife Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for MetLife and related companies with MarketBeat.com's FREE daily email newsletter.